Vertigo News and Research

RSS
Often missing in the health care debate: Women’s voices

Often missing in the health care debate: Women’s voices

Researchers provide insights into effects of microgravity on bone tissue

Researchers provide insights into effects of microgravity on bone tissue

Sighted people can be trained to use echolocation to estimate sizes of enclosed spaces

Sighted people can be trained to use echolocation to estimate sizes of enclosed spaces

Vestibular thresholds begin to increase above age 40, new study finds

Vestibular thresholds begin to increase above age 40, new study finds

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Novartis gets three FDA approvals for expanded use of biologic drug to treat rare autoinflammatory diseases

Noise levels in nightclubs may induce hearing loss

Noise levels in nightclubs may induce hearing loss

UTSW surgeons remove acoustic neuromas through small incisions in the ear canals

UTSW surgeons remove acoustic neuromas through small incisions in the ear canals

Study finds older adults who sustain wrist fractures more likely to have poor balance

Study finds older adults who sustain wrist fractures more likely to have poor balance

Nearly 3.3 million children in U.S. have dizziness or balance problem

Nearly 3.3 million children in U.S. have dizziness or balance problem

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

Results from STRIVE trial of enzalutamide versus bicalutamide in CRPC published in Journal of Clinical Oncology

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

FDA permits Sound Pharmaceuticals to start SPI-1005 clinical trial for treatment of Meniere's Disease

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Hospira announces TGA approval of Inflectra (infliximab) for treatment of eight inflammatory conditions

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Enzalutamide Phase 2 study for AR positive triple-negative breast cancer meets primary endpoint

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

National survey shows that most women don't know risks or symptoms of stroke

National survey shows that most women don't know risks or symptoms of stroke

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

Astellas Pharma, Medivation announce topline results from enzalutamide Phase 2 STRIVE trial

23andMe announces publication of genome-wide association study of motion sickness

23andMe announces publication of genome-wide association study of motion sickness

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Whole exome sequencing helps Mayo Clinic neurologist solve a medical mystery

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures

FDA accepts Eisai's sNDA for perampanel drug for treatment of PGTC seizures